Bezuclastinib is an investigational new drug that is being evaluated for the treatment of gastrointestinal stromal tumors and systemic mastocytosis. It acts as an inhibitor of tyrosine-protein kinase KIT.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.